- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 17, 2026 | 162.52M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 151.71M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 124.62M sh |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$150.25K |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | −$7.95K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2.69M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | −$2.44M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$1.56M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | −$1.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.32M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $1.12M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.74M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $2.51M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $314.59K |
| Current Assets | Q1 2026 · Sep 30, 2025 | $320.53K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $391.6K |
| Total Assets | Q1 2026 · Sep 30, 2025 | $409.22K |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$0.01 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | −$0.01 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $185.88K |
| Sga Expense restated | Q1 2026 · Dec 31, 2024 | $1.06M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$521.64K |
| Net Income | Q1 2026 · Dec 31, 2024 | −$1.34M |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$475.02K |
| Operating Income | Q1 2026 · Dec 31, 2024 | −$1.31M |
| Capex | Q1 2026 · Dec 31, 2024 | $1.73K |